WHO ICTRP trial
Comparative assessment of the absorption of a single oral dose of ipratropium…
ACTRN12614001098628 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12614001098628 |
|---|---|
| Public title | Comparative assessment of the absorption of a single oral dose of ipratropium bromide in healthy male and female volunteers with and without concurrent oral charcoal blockade. |
| Scientific title | A single dose, randomized, open label, crossover comparative bioavailability study of ipratropium bromide in healthy male and female volunteers under fasting conditions with and without concurrent oral charcoal blockade. |
| Primary sponsor | Zenith Technology Corporation Limited |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | New Zealand |
| Conditions | Bioavailability study conducted in healthy volunteers comparing ipratropium bromide administered with and without concurrent charcoal dosing with no health condition or problem studied. Although this study is being conducted in healthy… |
| Interventions | Single dose, crossover study design whereby each participant receives the formulation of ipratropium bromide (1 x 500 mcg) on one occasion with oral charcoal administered pre-dose and at specified times up to 4 hours post dosing and on one… |
| Registration date | Oct 16, 2014 |
| Target size | 24 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: